38117094|t|Combining Multifunctional Delivery System with Blood Brain Barrier Reversible Opening Strategy for The Enhanced Treatment of Alzheimer's Disease.
38117094|a|Alzheimer's disease (AD) is a neurodegenerative illness characterized by intracellular tau phosphorylation, beta-amyloid (Abeta) plaques accumulation, neuroinflammation and impaired behavioral ability. Owing to the lack of effective brain delivery approaches and the presence of the blood brain barrier (BBB), current AD therapeutic endeavors are severely limited. Herein, we elaborately combined a multifunctional delivery system (RVG-DDQ/PDP@siBACE1) with an AKT agonist (SC79) for facilitating RVG-DDQ/PDP@siBACE1 to target and penetrate BBB, enter brain parenchyma, and further accumulate in AD brain lesion. Moreover, compared with the unitary dose of RVG-DDQ/PDP@siBACE1, this collaborative therapy strategy exhibited a distinctive synergistic function including scavenging reactive oxygen species (ROS), decreasing of Abeta production, alleviating neuroinflammation by promoting the polarized microglia into the anti-inflammatory M2-like phenotype and significantly enhancing the cognitive functions of AD mice. More strikingly, according to our results, we found an innovative signaling pathway "lncRNA MALAT1/miR-181c/BCL2L11" that can mediate the neuronal apoptosis of AD. Taken together, combining brain targeted delivery system with non-invasive BBB opening can provide a promising strategy and platform for targeting treatment of AD and other neurodegenerative diseases. This article is protected by copyright. All rights reserved.
38117094	125	144	Alzheimer's Disease	Disease	MESH:D000544
38117094	146	165	Alzheimer's disease	Disease	MESH:D000544
38117094	167	169	AD	Disease	MESH:D000544
38117094	176	201	neurodegenerative illness	Disease	MESH:D019636
38117094	268	273	Abeta	Gene	11820
38117094	297	314	neuroinflammation	Disease	MESH:D000090862
38117094	464	466	AD	Disease	MESH:D000544
38117094	578	585	RVG-DDQ	Chemical	-
38117094	586	597	PDP@siBACE1	Chemical	-
38117094	607	610	AKT	Gene	11651
38117094	620	624	SC79	Chemical	-
38117094	643	650	RVG-DDQ	Chemical	-
38117094	651	662	PDP@siBACE1	Chemical	-
38117094	742	757	AD brain lesion	Disease	MESH:D001927
38117094	803	810	RVG-DDQ	Chemical	-
38117094	811	822	PDP@siBACE1	Chemical	-
38117094	926	949	reactive oxygen species	Chemical	MESH:D017382
38117094	951	954	ROS	Chemical	MESH:D017382
38117094	971	976	Abeta	Gene	11820
38117094	1001	1018	neuroinflammation	Disease	MESH:D000090862
38117094	1046	1055	microglia	Disease	
38117094	1070	1082	inflammatory	Disease	MESH:D007249
38117094	1156	1158	AD	Disease	MESH:D000544
38117094	1159	1163	mice	Species	10090
38117094	1257	1263	MALAT1	Gene	72289
38117094	1264	1272	miR-181c	Gene	723819
38117094	1273	1280	BCL2L11	Gene	12125
38117094	1325	1327	AD	Disease	MESH:D000544
38117094	1489	1491	AD	Disease	MESH:D000544
38117094	1502	1528	neurodegenerative diseases	Disease	MESH:D019636
38117094	Association	12125	72289
38117094	Association	72289	723819
38117094	Association	MESH:D000544	72289
38117094	Association	12125	723819
38117094	Association	MESH:D001927	11651
38117094	Association	MESH:D000544	12125
38117094	Association	MESH:D000544	723819

